EDGAR Filing Documents for 0001753926-23-001178

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001753926-23-001178

Filing Date

2023-09-01

Accepted

2023-09-01 16:59:21

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-1 AMENDMENT	g083667_s1a.htm	S-1/A	2253698
2	FORM OF UNDERWRITING AGREEMENT	g083667_ex1-1.htm	EX-1.1	258479
3	SIDE LETTER TO CONTRIBUTION AGREEMENT	g083667_ex2-2.htm	EX-2.2	11561
4	FORM OF CERTIFICATE OF DESIGNATION	g083667_ex3-4.htm	EX-3.4	265000
5	FORM OF CERTIFICATE OF DESIGNATION	g083667_ex3-5.htm	EX-3.5	116275
6	THIRD AMENDED AND RESTATED INVESTOR PROMISSORY NOTE	g083667_ex4-4.htm	EX-4.4	40421
7	SIDE LETTER TO SECOND AMENDED AND RESTATED INVESTOR PROMISSORY NOTE	g083667_ex4-5.htm	EX-4.5	27220
8	AMENDED AND RESTATED EMPLOYMENT AGREEMENT (CHRISTIAN KOPFLI)	g083667_ex10-2.htm	EX-10.2	83404
9	SECURITIES PURCHASE AGREEMENT (SEPTEMBER BRIDGE FINANCING)	g083667_ex10-6.htm	EX-10.6	510130
10	SECURITY AGREEMENT (SEPTEMBER BRIDGE FINANCING)	g083667_ex10-7.htm	EX-10.7	230746
11	SUBORDINATION AND INTERCREDITOR AGREEMENT (SEPTEMBER BRIDGE FINANCING)	g083667_ex10-8.htm	EX-10.8	117568
12	FORM OF SECURITIES PURCHASE AGREEMENT (SERIES B PREFERRED STOCK)	g083667_ex10-9.htm	EX-10.9	63048
13	FORM OF REGISTRATION RIGHTS AGREEMENT	g083667_ex10-10.htm	EX-10.10	118454
14	FORM OF AMENDMENT TO CHROMOCELL THERAPEUTICS CORPORATION 2023 EQUITY INCENTIVE P	g083667_ex10-12.htm	EX-10.11	3647
15	CONSENT OF MARCUM LLP	g083667_ex23-1.htm	EX-23.1	4567
16	GRAPHIC	img001_v5.jpg	GRAPHIC	3591
17	GRAPHIC	img001.jpg	GRAPHIC	6503
	Complete submission text file	0001753926-23-001178.txt		4119353

Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902

Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313

Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)